Welcome to our dedicated page for PARKERVISION SEC filings (Ticker: PRKR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
ParkerVision, Inc.'s SEC filings document an OTCQB-traded Florida corporation focused on proprietary RF technologies, wireless applications, licensing, and patent enforcement. Its 8-K filings report operating results, legal and appellate developments involving patent claims, and material events that affect the company's capital structure and disclosure record.
The filing record also covers registered direct common stock offerings under a Form S-3 shelf registration statement, exchanges of convertible promissory notes for common stock, unregistered equity issuance disclosures, and executive compensation arrangements under the company's long-term incentive plan. These documents address governance approvals, share-based awards, financing terms, and risk references tied to patent proceedings and funding activity.
ParkerVision, Inc. filed a prospectus supplement updating a resale registration that permits selling stockholders to resell up to 12,800,000 shares of common stock, including shares issuable from convertible notes and a five-year warrant. The company is not selling shares and will only receive cash if the warrant is exercised, up to $800,000, which it plans to use for patent enforcement, working capital, and general corporate purposes.
Attached financials for the quarter ended June 30, 2026 show cash of $2.5 million, working capital of about $0.8 million, a six‑month net loss of $1.4 million, and an accumulated deficit of $457.0 million. Large fair‑valued obligations include a secured contingent payment obligation of $39.0 million and unsecured contingent obligations of $5.8 million. Management states there is substantial doubt about the company’s ability to continue as a going concern over the next year absent successful licensing outcomes and/or new financing.
ParkerVision, Inc. reported financial results for the quarter and six months ended June 30, 2026 and provided an update on ongoing patent litigation. Oral argument in its Federal Circuit appeal in ParkerVision v. Qualcomm was held on June 1, 2026, and the appellate decision remains pending. The company also noted expected revised scheduling orders in its western district of Texas cases following Judge Albright’s planned retirement.
For the three months ended June 30, 2026, ParkerVision recorded net income of $148 thousand, compared with a net loss of $1,634 thousand a year earlier, with no licensing revenue and a $1,723 thousand gain from the change in fair value of contingent payment obligations. Six‑month net loss narrowed to $1,405 thousand from $5,433 thousand. Cash and cash equivalents were $2,501 thousand at June 30, 2026, down from $4,360 thousand at December 31, 2025, after $1,737 thousand of net cash used in operating activities in the first half of 2026. Contingent payment obligations totaled $44,763 thousand, and shareholders’ deficit was $44,610 thousand.
ParkerVision Inc. director Anthony B. Bowers has filed an initial Form 3 showing his equity stake in the company. He holds 165,000 shares of Common Stock directly. He also holds a Nonqualified Stock Option covering 300,000 shares of Common Stock at an exercise price of $0.20 per share, expiring on May 19, 2031. According to the footnote, this option was granted on May 19, 2026 for his first year of Board and committee service and vests in two equal installments on November 19, 2026 and May 19, 2027.
ParkerVision, Inc. files a Prospectus Supplement registering 9,387,500 shares of Common Stock for resale by the selling shareholders. The registered shares consist of 2,843,750 issued shares, 6,343,750 shares issuable upon conversion of Convertible Notes at a fixed conversion price of $0.16 per share, and 200,000 shares issuable upon exercise of Options. The company will not receive proceeds from resale by the selling shareholders; if the Options are exercised for cash, the company could receive up to $42,620 in gross proceeds. This supplement updates the Prospectus with information furnished on May 21, 2026.
ParkerVision, Inc. registers 16,638,353 shares of Common Stock for resale by selling shareholders.
The shares are issuable upon conversion of convertible promissory notes dated between May 10, 2022 and August 3, 2022 at a fixed conversion price of $0.13 per share. This Prospectus Supplement (dated May 21, 2026) supplements the Prospectus dated August 22, 2022 and attaches a Form 8-K furnished on May 21, 2026. The resale registration covers shares held by the selling shareholders named in the Prospectus.
ParkerVision, Inc. files a Prospectus Supplement registering 1,578,946 shares of Common Stock for resale by a selling stockholder.
The registration covers an aggregate of 1,052,631 shares and 526,315 shares underlying warrants issued under a December 14, 2021 agreement. The company will not receive proceeds from resales; if the Warrants are exercised for cash, ParkerVision would receive up to $526,315, which it expects to use for general working capital, including payment of litigation expenses. The supplement attaches a Form 8-K disclosing that director Lewis Titterton resigned effective May 15, 2026 and that Anthony Bowers was appointed to the Board and its Audit and Compensation Committees on May 19, 2026.
ParkerVision, Inc. is updating a resale prospectus to register 13,342,953 shares of Common Stock for resale by selling stockholders under the Prospectus Supplement dated May 21, 2026. The shares consist of several issuances, including 7,962,722 shares issued under earlier purchase agreements, 3,230,942 shares plus 1,619,289 shares underlying warrants, and 530,000 shares issued for services.
The company states it will not receive proceeds from resale of the registered shares; however, if the Warrants are exercised for cash, the company would receive up to $2,833,756, which it expects to use for general working capital, including payment of litigation expenses. The supplement attaches a Form 8-K that discloses a director resignation on May 15, 2026 and the appointment of a new director on May 19, 2026. The company’s common stock trades on the OTCQB under the symbol PRKR.
ParkerVision, Inc. registers 5,871,584 shares of Common Stock for resale by selling stockholders under a Prospectus Supplement dated May 21, 2026. The company will not receive proceeds from these resales. The supplement attaches a Form 8-K filed May 21, 2026, which furnishes a press release.
The Form 8-K discloses a director resignation and board appointment: May 15, 2026 resignation of Lewis Titterton (retirement) and appointment of Anthony Bowers on May 19, 2026, who joins the Audit and Compensation Committees and will receive standard non-employee director compensation and the company’s standard indemnification agreement.
ParkerVision, Inc. files a prospectus supplement registering 16,809,295 shares of Common Stock for resale by selling stockholders under its April 28, 2020 prospectus. The supplement notes the company will not receive proceeds from those resales; cash proceeds up to $3,900,000 may result if certain warrants are exercised.
The filing also furnishes a Form 8-K reporting the resignation of director Lewis Titterton due to retirement and the Board's appointment of Anthony Bowers to fill the vacancy and to serve on the Audit and Compensation Committees.